A Study to Assess Dose-Response, Efficacy (Immunogenicity) and the Safety of GC1109
Clinical trial NCT01624532 · COMPLETED
Trial details
- NCT number
- NCT01624532
- Sponsor
- Green Cross Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-14
- Primary completion
- 2022-08-02
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.